Basic Information
LncRNA/CircRNA Name | circFOXM1 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, RNA immunoprecipitation, luciferase analysis, RNA pull-down, and rescue assay |
Sample | non-small cell lung cancer tissues |
Expression Pattern | up-regulated |
Function Description | We found that circFOXM1 was significantly upregulated in NSCLC tissues, and its upregulation was positively correlated with advanced clinical stage and poor prognosis of NSCLC patients. Gain or loss-of-function assay showed that circFOXM1 promoted cell proliferation and cell cycle progression. |
Pubmed ID | 32228656 |
Year | 2020 |
Title | circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D |
External Links
Links for circFOXM1 | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |